The authors have developed the new positron emitting metal and fluorescence labeling protocol of ε-amino group of lysine through their rapid 6π-azaelectrocyclization. Using the same reaction, the small organic molecules could also be introduced on the amino groups of the living cell surface with simple operations under quite mild conditions, establishing the chemistry-based cell surface engineering with complex-type N-glycans. PET and the noninvasive fluorescence imaging of the N-glycoproteins and the world's largest N-glycoclusters, mimicking the natural glyco-bioenvironment, for the first time visualized the differences in their in vivo dynamics and excretion pathway depending on the presence of the non-reducing end sialic acid as well as their linkages to the galactose residue. The authors also synthetically developed the artificial lymphocytes to target the tumors in living animals by introducing the complex-type N-glycans on the cell surfaces.
A. Introduction
Asparagine-linked oligosaccharides (N-glycans) are involved in a variety of important physiological events, including cell-cell and cell-protein interactions, quality control of the proteins, signal transduction in immune responses, folding of the proteins, and so on (1) . Moreover, it has long been known that the sialic acids in N-glycans on soluble proteins or peptides enhance circulatory residence (2). These important findings and previous efforts in investigating N-glycan functions have been mostly based on in vitro experiments using isolated lectins, cultured cells, and dissected tissues. Now, interest has shifted to the in vivo functions and dynamics of these glycans and the targeting to the desired organs or tumors using the glycans; molecular imaging is the most promising tool to visualize the "on-time" N-glycan dynamics in vivo. Recently, biomolecule-based tracers such as peptides and antibodies, in addition to the small organic molecules (3), have actively been investigated to visualize in vivo dynamics and target specific organs (4). Although fluorescence imaging is the method of choice due to the convenient experimental and detection procedures at the small animal levels (such as mouse), MR (magnetic resonance) and the PET (positron emission tomography) imaging, which have technologically improved sensitivity, are well-suited even for diagnostic applications.
18 F-FDG as a successful example (2-deoxy-2-[
18 F]fluoro-D-glucose), where the C2-hydroxyl group of glucose was exchanged with the β-emitter 18 F, is widely applied to the tumor diagnosis as a Food and Drug Administration-approved PET-radiopharmaceutical (5). By using these advanced imaging apparatus, the in vivo dynamics of the glycans, of which target receptors or interacting organs are known, can directly be investigated as the images. Alternatively, the imaging of the glycans with unknown functions, could bring us a new insight on the biological significance of individual glycans.
Nevertheless, except the case of 18 F-FDG, technically a monosaccharide, a very few imaging trials of glycans have been reported. A single molecule of the N-glycan, either obtained from a natural or synthetic source (6) , is readily degraded in the blood and/or excreted from the body (7). The bioactivity and the highly selective recognition of the oligosaccharides might be derived from the pattern recognition through the multivalency and/or heterogeneous environment, i.e., on cell surfaces that are composed of oligosaccharide clusters along with other biomolecules. Therefore, efficiently mimicking a N-glycan-involved bioenvironment (termed as glyco-bioenvironment), e.g., by conjugating the N-glycans to the liposomes, to the clusters, or even to the surface of the cells, may provide information on the "in vivo dynamics" of N-glycans. Furthermore, based on these glycoconjugate imaging, we could explore the glycans which efficiently target the inflammation or tumor, and those selectively accumulate in the nerve systems, lymphatic organs, or spleen. The recent successful noninvasive imaging and biodistribution study of glycans and/or glycoconjugates dealt with natural-and neoglycoproteins, liposomes, and nanoparticles (8) .
We have been applying the rapid azaelectrocyclization, which was developed by ourselves, to the PET or noninvasive fluorescence imaging of biomolecules in order to analyze the dynamics of glycans, peptides, and proteins in vivo, and to develop the biomolecule-based diagnosis tracers for inflammation and tumors. Thus, we developed the highly efficient positron emitting metal and fluorescence labeling probes for the N-glycoconjugates by designing the rapid azaelectrocyclization with the amino groups (4,9), and achieved the noninvasive in vivo imaging of the N-glycoproteins (4,9) or the whole living cells (10) . Furthermore, the world's largest N-glycoclusters with molecular mass of 50 kDa, which efficiently mimic the multivalency effects in vivo, could be prepared, and their imaging studies successfully visualized the remarkable dependence of the non-reducing end sialic acid and its linkages to galactose on the clearance and the organ-specific accumulation (11) . Furthermore, we developed the method for introducing the N-glycans on living cell surfaces using the same azaelectrocyclization (cell surface glycan engineering), and the glycan-engineered artificial cells were used as the whole cell-based imaging tracers of tumors, thus establishing the new strategy for tumor targeting (12) . In this review, we would like to first discuss our new electrocyclization-based labeling of biomolecules, providing the reactivity profiles in details, and then describe our recent trials on the in vivo imaging of the N-glycoconjugates.
B. Development of New Labeling Probes of Lysines through Rapid Azaelectrocyclization
Generally, PET or SPECT (single-photon emission computerized tomography) experiments of the "biomolecules", including peptides, proteins an antibodies, is achieved by conjugation to metal chelating agents such as DOTA (1,4,7,10-tetraazacyclodecane-1,4,7,10-tetraacetic acid) or DTPA (diethylenetriaminepentaacetic acid) prior to radiolabeling with a suitable radioactive metal (Fig. 1A) . DOTA is preferentially used due to the preferable kinetics for metal incorporation as well as high thermodynamic stability of the complexes with any metals (4). An example of positron emitting metal-DOTA conjugates for PET is tumor diagnosis using 68 Ga-DOTA-octreotide, a metabolically stable analog of 68 Ga-DOTA-octreotide which was injected into patients suffering from meningiomas, could detect even the smallest tumors of 7 mm diameter, achieving much higher sensitivity than 18 F-FDG PET or MRI. Alternatively, other natural peptides, monoclonal antibodies, minibody, (a smaller fragment of monoclonal antibody (mAb) showing better biodistribution), or even mRNA and PNA (peptide nucleic acid), have also been reported as the DOTA-based PET probes of biomolecules. These recent trend for PET imaging of biomolecules is summarized in detals in the authors' review (4).
In most cases, the chelating agent, DOTA, can be introduced via a reaction of N-terminal amino groups or lysine ε-amino groups with DOTA-O-sulfosuccinimidyl ester, NHS reagent (Fig. 1A) . However, the reactivity of the activated DOTA ester is not high, and the labeling requires high reaction concentrations (10 -3~1 0 -4 M for biomolecules, 10 -1 M for reagents) and long reaction times (2-24 hours) at room temperature. The conjugate efficiency is usually not high (20-30 %) . In most cases, therefore, the method requires a large quantity of sample, in worst cases, as much as 4-20 mg to maintain high reaction concentrations, hence to efficiently prepare the DOTA-conjugates. Importantly, labeling under such high reagent concentrations indiscriminately modifies many lysines, including the key lysines for the activity.
Under such circumstances, new chemical approaches towards the protein modification, employing advanced organic reactions, including Cu(I)-catalyzed Huisgen [2+3] cycloaddition (13) , Staudinger reaction (14) and ligation using the strained acetylenes under the Cu-free conditions as the improved version of Huisgen protocol (15, 16) , have been reported ( Fig. 2A) . By these chemical protocols, the protein labeling could be achieved without affecting the activity, when the azide groups were selectively introduced at the desired positions within the amino acid sequences of the target proteins; such protocols are referred to be "bioorthogonality (17)". However, although the genetically engineering methods which efficiently express the unnatural amino acids, i.e., azide-containing residues, into the natural proteins, have actively been investigated, they are still not trivial issues to us. These authors believes that such bioorthogonal methods could soon bring the breakthrough to the molecular imaging and the chemical biology fields, but the generality and broader applicability to chemists, biologists, as well as the physicians, still remains to be explored.
We have recently established the new labeling method of the peptides and the proteins, utilizing the rapid azaelectrocyclization, which was discovered during our research on the mechanistic investigation of the enzyme inhibition by natural product derivatives ( Fig. 1B ) (9). Thus, the unsaturated aldehydes such as 1 rapidly and quantitatively reacted with non-branched primary amines, such as ε-amino group of lysine, to yield 1,2-dihydropyridines as irreversible products through the "accelerated" 6π-azaelectrocyclization of the intermediary Schiff base (1-azatriene) (18); the presence of the C4-electron withdrawing groups and C6-conjugated moieties contribute the strong HOMO/LUMO interaction within 1-azatriene system, hence the reverse electron demanded concerted reaction is accelerated. Schiff base formation is the reversible process, especialy in the aqueous solution, but the following "irreversible" rapid azaelectrocyclization shifts the equibrilium towards the dihydropyridine formation, which in turn accelerates the rate of the whole cascade process. A new DOTA-labeling probe 1a was synthesized even on a 50 g scale according to the scheme in Fig. 3 , the Stille coupling as the key step. Currently, our amino-labeling probes in Fig. 3 , which show the excellent labeling efficiency and can readily be applied using the quite simple procedures, were developed as a labeling kit "STELLA + "; it could be utilized in near future for molecular biology, diagnosis, and the other bio-directed research with broader applications (9e).
As expected, the aldehyde probe 1a prepared in Fig. 3 showed the excellent reactivity for labeling of the biomolecules. Thus, the 10 -6 M -10 -8 M solution of DOTA-STELLA + 1a quantitatively labeled the lysines on peptides and proteins within 5-30 min in various buffer solutions (pH = 6-9) (Fig. 1B) . Detailed discussion is provided in the original papers (9,10), but the author's labeling via azaelectrocyclization can be performed within a very short time under extremely low concentrations of both probe and the lysines in comparison with the conventional NHS method. Under such mild labeling conditions, ε-amino groups of lysines are preferentially labeled to those N-terminal amines. Steric accessibility of the lysines also affects their labeling selectivity; although reactions with internal lysines in the protein tertiary structures are very slow, lysines at the protein's surface, which are usually not involved in the protein activity, can react rapidly; therefore, labeling occurs preferentially at surface positions and the activity is retained. On the other hands, the conventional NHS method necessitates much higher reaction concentrations due to the low reactivity profile of the activated esters, therefore resulting in the non-selective lysine modification.
Moreover, dihydropyridines as the electrocyclization products, which retain cationic charges as those of the inherent lysines, should contribute to the retention of the protein activity. For instances, the 10 -7 M solution of anti-GFP and EGF receptor (EGFR) antibodies (as litle as a few pg-μg, a few pmol of the samples) was successfully labeled by 1c in 30 min at room temperature; this probe preferentially labeled the more accessible Fc fragment with two fluorophore molecules, while retaining its GFP and EGFR recognition activity as those of the intact mAb (9a) . While the reaction with the azide functions being introduced at the specific position of the proteins, which was shown in Fig. 2 , is the "bioorthogonal", the authors' azaelectrocyclization as well as the conventional succinimidyl ester methods are categolized as "nonbioorthogonal". Nevertheless, the unique reactivity of the azaelectrocyclization as described above could satisfy some of requirements for "bioorthogonal reaction" (17) , namely, (1) fast (kinetics), (2) non-toxic to the biological environment (biocompatibility), or (3) selecvtive at the target molecules in vivo (selectivity), etc.; thus, we could propose and realized a new concept of the "pseudo-bioorthogonal reaction, through the development of the authors' rapid azaelectrocyclization. Not only for the DOTA-probe 1a, the established route in Fig. 3 could but also be used for preparing the general fluorescence probes; various biomolecules are efficiently labeled by fluorescence-STELLA + 1b-d (9e), i.e., coumarin-, TAMRA-, and Cy5-fluorescences (Figs. 1 and 3) . Additionally, paramagnetic metal Gd 3+ could be chelated in the DOTA unit of 1a prior to peptide labeling (1a: M = Gd 3+ in Fig. 1 ); this new process should allow valuable and/or unstable materials, which might decompose during metal-incorporation to DOTA afterwards, to be labeled for MRI purposes. Efficient labeling protocol in our hands, we have investigated the noninvasive imaging of the N-glycans and glycoconjugates.
C. PET Imaging of Soluble Glycoproteins: Effects of Sialo-N-Glycans on Circulatory Residence of Proteins
Effects of non-reducing end sialic acid residues on the circulatory residence of the glycoproteins were examined by combined use of the labeling probe STELLA + and MicroPET imaging (Fig. 4) (4,9) . According to the established procedure above, orosomucoid and asialoorosomucoid as the representative mucin-type glycoproteins, which are available in only small amounts (~10 μg of glycoproteins), were labeled successfully and 2 and 3 units of DOTA were incorporated by incubating the respective protein with DOTA-STELLA + 1a for 30 min. The DOTA-glycoprotein adducts obtained were then treated with 68 Ga 3+ (readily obtained from 68 Ge 3+ ) as a β + emitting radiometal (19) for PET. Approximately, 1 μg (200 pmol) of the 68 Ga-DOTA-labeled glycoprotein tracers were then administered from the tail vein of the rabbit and the dynamic PET images were obtained (Fig. 4) . PET of these two proteins successfully visualized asialoglycoprotein as well as its decomposed products being rapidly moved to the kidney in 30 min and then cleared in 240 min much faster than orosomucoid. Asialoorosomucoid was also transfered to gallbladder, hence the excretion pathway through the liver to the gallbladder was suggested; the results show that the asialoorosomucoid without sialic acids is rapidly cleared from the body. That is, the sialic acid residue on the nonreducing end of the N-glycans contributes to the stability of glycoproteins in the blood. It has been well known that the introduction of sialic acid of the N-glycans extends the life time of the glycoproteins in vivo (2), e.g., erythropoietin (EPO) (2b) or insulin (2c). To the best of our knowledge, the results in Fig. 4 achieved the first visualization of sialic aciddependent circulatory residence of glycoproteins. Furthermore, we observe from Fig. 4 that the asialoglycoprotein strongly accumulated in the spleen and the lung in a time-dependent manner, thus showing such a significant difference in the biodistribution in the presence and absence of the sialic acid residues in the glycoproteins. It is noted that the spleen is an organ located in the abdomen of the body, involved in the secondary lymphoid organs. It can function as part of the immune system, i.e., by phagocytosis-mediated defense mechanism through the reticuloendothelial system (RES) or by the activation and regulation of the systemic and mucosa immunity; the antigen-specific antibodies could be produced by interacting the T-cells with the mature B-cells. Although it await for the further investigation to rationale the accumulation of the asialoglycoprotein in the spleen, these imaging results in Fig. 4 may suggest the negative regulation effects of the sialo-N-glycoproteins on the immune system through the interaction with Siglec 2 (CD22) (20,21), a Neuα(2-6)Galspecific lectin, which is overexpressed on mature B-cells or T-cells. Overall, when applying our labeling probe STELLA + , the circulatory residence of the glycoproteins could readily be visualized by PET, hence the results in Fig. 4 would give a promising opportunity for developing the proteins as the future pharmacological and/or clinical applications.
D. Development of the World's Largest N-Glycoclusters and Their In Vivo Dynamics by Noninvasive Imaging
As visualized the significant effects of N-glycan 68 Ga-DOTAasialoorosomucoid in some peripheral organs. Radioactivity of each 68 Ga-DOTA-labeled glycoclusters was adjusted to 10 MBq, prior to the injection. structures on proteins dynamics in vivo, our next concern was the dynamics of the N-glycan themselves (11) . As noted in Introduction, single molecules of the N-glycans (monomeric glycan), however, in general are not suited as the imaging tracer due to the small size and the weak interaction with the sugar binding proteins. Consequently, they are readily excreted through the kidney via the biofiltration (7). Most of the glycans in nature are therefore enhancing their interactions and target selectivity by forming the glycocluster (termed as cluster effects and/or multivalency effects) (22). On the other hands, the natural glycoclusters are often consisted of the several kinds of the glycans (termed as glycoform), thus highly diversifying the glyco-bioenvironment; such heterogeneous glycoclusters could be responsible for regulating and/or adjusting the glycan-dependent dynamics and functions in vivo (1) . In order to mimic such glyco-bioenvironment, we initially designed the homogeneous dendrimer-type glycoclusters (11) . Examples of the large glycodendrimers consisting of the N-glycans with complex structures have not been reported (23), we efficiently synthesized the world's largest N-glycoclusters with molecular mass of 50 kDa (Fig. 5A) . Thus, 4, 8, and 16 molecules of N-glycans (24) were introduced on the Ga-DOTA-labeled glycoclusters was adjusted to 10 MBq, prior to the injection; H: heart; K: kidney; L: liver; B; urinary bladder; GB: gallbladder.
polylysine-based dendrimer core with the terminal histidine and propargyl glycine residues, by Cu(I)-mediated Huisgen cycloaddition; by applying the authors' "self activating click reaction" which utilizes the histidine derivatives as the internal activators (25) , various complex-type N-glycans were quantitatively clustered at room temperature for 40 min. Terminal amino groups of these glycoclusters were subsequently labeled by 68 Ga-DOTA (labeling using STELLA + 1a) or near-infrared fluorescence, Cy5-fluorophore (650 nm, using STELLA + 1d) through rapid 6π-azaelectrocyclization for PET and fluorescence imaging in BALB/c nude mice (Fig.  5B) .
First of all, the in vivo dynamics between the generations of the clusters, namely those between 4-mer, 8-mer, and 16-mer containing the bis-Neuα(2-6)Gal structure at the non-reducing end (see structure 2a in Fig. 5A ), remarkably differed; although 4-mer and 8-mer were rapidly and almost completely cleared through the kidney over 1 h, the radioactivity derived from 16-mer 2a was still retained in the body after 4 h, resulting in the accumulation in the liver, but was excreted slowly from the kidney/urinary bladder and from the gallbladder (Fig. 5B ). The differences in the clearance properties between the dendrimer generations may be due to their molecular size (26). Alternatively, the degree of negative charge and/or that of the hydrophilicity of the clusters, i.e., hydrophilic N-glycans vs. the hydrophobic polylysine backbone occupying the surface on the clusters may affect the rapid clearance through the kidney (27) . Hence, the 16-mer cluster should be well suited for efficiently visualizing the in vivo dynamics of N-glycan in living animals.
We subsequently examined the effects of the N-glycan structures on their in vivo dynamics and the biodistribution using the 16-mer clusters 2a-2c (Fig. 5B) . Unlike bisNeuα(2-6)Gal-case 2a, asialo-glycan cluster 2b rapidly cleared through the kidney to the bladder, although some accumulation was observed in the liver over 4 h, because the asialoglycoprotein receptors are highly expressed in this organ (2a) . The results are consistent with the PET analyses of glycoproteins as described in the previous section, that the sialic acid contributes to the stabilization of the glycoclusters in the body. However, bis-Neuα(2-3)Gal-case 2c, which also contains sialic acid but α-linking to the 3-OH of galactose, was readily excreted through the kidney/urinary bladder over 1h, substantially different phenomena from those of bis-Neuα(2-6) Gal-case 2a. Since the Neuα(2-3)Gal moieties cannot usually be found in the serum proteins, the mamarian blood circuratory systems might precisely recognize the sialic acid linkages to the galactose at the non-reducing end of the glycans. Namely, Neuα(2-3)Gal-cluster 2c is probably recognized as an invader and smoothly excreted by the vascular endothelial cells, erythrocytes, leucocytes, and via the phagocytosis by a macrophage; the smaller sized degradation products may be filtered in the kidney. Alternatively, the "excretion-escaping" mechanism by stimulating the immunosuppressive signals through the ITIM (immunoreceptor tyrosine-based inhibitory motif) molecules via Siglec families (20), may account for the higher stability of Neuα(2-6)Gal-cluster 2a. Thus, our dynamic PET images for the first time visualized the strikingly different in vivo dynamics as well as excretion pathways between the N-glycoclusters, which are sensitively regulated by the truncated structures at the non-reducing end, even by the linkages between the sialic acid and galactose. A biodistribution study of the glycoclusters 2a-e (16-mer) , which in addition to the clusters investigated above, include the glycans containing both Neuα(2-6)Gal and Neuα(2-3)Gal moieties, was performed in further detail using fluorescence imaging (Fig. 6) . Overall, these in vivo images clearly visualize the importance of "at least" one Neuα(2-6) Gal moiety in the circulatory residence of the N-glycoclusters in BALB/c nude mice, and these clusters 2a, 2d, and 2e eventually accumulated mostly in the liver, presumably due to the interaction with asialoglycoprotein receptor (2a,28-30) , and were also observed in the spleen after 4 h (Fig. 6A) . As in the sialoglycoprotein case described in the previous section, these glycoclusters might also interact with Siglec 2 on B-or T-cells.
Additionally, an examination of these glycoclusters in cancer model (human colon carcinoma: DLD-1, implanted to the left femoral regions) was performed. Although these clusters did not target the tumor tissue, the excretion rates of the asialo-glycocluster 2b was considerably suppressed in glycoclusters were administered from the tail vein of the mice (n=3, 500 pmol, 100 μL/mouse) and whole body scans were performed from the front side by eXplore Optix, GE Healthcare, Bioscience (excitation at 646 nm, emission 663 nm), 4 h after injection. Data was normalized. H: heart; L: liver; B: urinary bladder; SP: spleen. the cancer mice (Fig. 6B) . Moreover, the accumulation of the glycoclusters 2a, 2d, and 2e, which contain the Neuα(2-6)Gal moiety, was not detected in the spleen. Thus, the markedly different excretion observed from those in normal mice could make these N-glycoclusters applicable to a new class of the tumor diagnostic tracers.
E. Live Cell Surface Labeling and Imaging through Rapid Azaelectrocyclization, and Tumor Targeting in Living Animals Based on Chemistry-Based Cell Surface Engineering
Our azaelectrocyclization-based probe, STELLA + , can also fluorescently label a whole living cell (Fig. 7) (10) . For instances, the C6 glioma cells could be efficiently labeled by treating with even 10 -8 M PBS buffer solution of TAMRA-STELLA + or Cy5-STELLA + (1c, d) at either 24 ˚C or 37 ˚C only for two minutes. Similar to the protein-labeling cases, the azaelectrocyclization using such extremely diluted probe concentration, selectively proceeds at the highly expressed and hence the accessible amino groups on cell surface constituents, i.e., lysines of membrane proteins and/or ethanol amine derivatives without the probe internalization, and therefore without interfering with their native functions. As exemplified by Bertozzi's and Boons' research, the live cell labeling is now actively investigated, e.g., the methods utilize the Staudinger ligation (14) or the cell-friendly 1,3-cycloaddtion under the copper-free conditions (15, 16) with the azides on the cell surfaces (Fig. 2B) . Nevertheless, these require in advance an expression of the azide functions on the cell surfaces by making use of the sugar metabolic pathway, that usually takes for a few days. Our STELLA + , on the other hands, is the only reaction-based probe, which can efficiently and directly anchor the labels on the cell surfaces through the bondforming organic reaction at the target functional groups, i.e., a Complex-type N-glycans and other functional molecules, such as biotin, could also be introduced on cell surfaces using the probes 1e and f (chemistry-based cell surface engineering) (Fig. 7) (12) ; thus, the probes 1e and f, which were prepared in situ through Staudinger ligation (14), were immobilized on cell surfaces through the azaelectrocyclization chemistry, by reacting with the live cells at 24 ˚C for 10-30 min. We have recently established the second-generation protocol as more efficient and general method, and the convenient cell surface engineering is now possible.
Based on the cell surface labeling and engineering established above, lymphocytes (1 mL, 1.0 x 10 5 cells) extracted from the abdominal cavity of the wild-type mice were labeled by Cy5-fluorescence (probe 1d, Fig. 7) , and the noninvasive fluorescence imaging was performed in the BALB/c nude mouse (Fig. 8A) (10) . The dynamic images provided the marked results that the trafficking of the cells into the spleen and the lymph nodes as the secondary lymphoid organs, was clearly visualized with exceptionally high imaging contrasts compared with those reported previously (4,31); thus, the observation highlights our azaelectrocyclization- based labeling in applying to a whole cell-based in vivo imaging (32) .
The fluorescence-labeled lymphocytes were then injected to the mouse of the cancer model, where the DLD-1 was implanted to the dorsal division of mouse; although they accumulated in the secondary lymphoid organs as those observed for the nude mice, no trafficking to the tumor tissues could be detected (Fig. 8B) (12) . On the other hands, we made a remarkable observation when the N-glycan probe 1f was introduced to the cell surface of the lymphocytes by using the procedures established in Fig. 7 (Fig. 9) ; namely, the chemically engineered cells still traffic to the secondary lymphoid organs, while they gradually began to accumulate into tumor region (TM) (Fig. 8C, Fig. 9 ). Although the imaging results in Fig. 8 cannot be explained on the biological basis by the currently available data in our hands, neither the native lymphocytes nor the complex-type N-glycan clusters traffic to the cancer regions on their own (Fig. 6B ) (11) . Therefore, the N-glycan-enriched lymphocytes might interact with the tumor via additional interaction with lectins on cancer cells. Alternatively, the interaction of Siglec and internal sialoglycans, responsible for the immunosuppressive signals (20), could be interrupted by the N-glycan externally introduced by the chemical engineering. Whatever the reasons are, the artificial cells, which could target the tumor in living animals, were efficiently prepared by applying the authors' chemical reaction (Fig. 9) . Although the correlation between the glycans introduction on cell surfaces and the target efficiency, the tumor selectivity depending on the N-glycan structures, the position on the cell surfaces where the glycans are chemically introduced, and the metabolic analysis of the glycans in vivo, should be throughout investigated for future 
F. Conclusion
We have described the noninvasive imaging of N-glycoproteins, N-glycoclusters, and N-glycan-engineered lymphocytes based on the authors' chemical bond-forming reaction, i.e., rapid azaelectrocyclization. A new strategy for tumor targeting using the live cells was also proposed. Since the authors' azaelectrocyclization using the labeling kit, STELLA + (9e), proceeds at the amino groups of the various biomolecules and the cell surfaces, it is quite rare and promising synthetic transformation, of which application is not restricted to the molecular imaging and the diagnosis fields, but is in more broader sense applicable to any kinds of chemical, biological and medical studies. These authors strongly hope that the STELLA + could be more widely and generally utilized in future, thereby the imaging of the various biomolecules are more common to us.
In future, when performing the in vivo imaging of the glycans in pursuit of elucidating their dynamics and analyzing the glyco-bioenvironment in vivo, and further applying to diagnosis and even clinical trials, we need to efficiently synthesize and mimic the heterogeneous glycobioenvironment, consisting the various glycan structures and the other biomolecules on the cell surfaces (33) . As described in Introduction, the various labels-containing liposomes or nanoparticles with the enhanced serum stability are recently developed. Heterogeneously immobilizing the glycans and the antibodies on their surfaces, the targeting of inflammations or tumors is actively investigated (8) . Alternatively, heterogeneous clusters consisted of two different glycans on the dendrimer template, were recently developed and these showed for the first time the enhanced and/or the decreased reactivity towards antibodies, that are sensitively affected by the neighboring glycans in the heterogeneous structures (34) . These results are in most of cases realized based on the advanced synthetic organic chemistry, e.g., immobilizing the various glycans and/or biomolecules on the liposomes or particles, conjugating efficiently and selectively (for functional groups) the glycans on dendrimer templates, etc. Thus, the synthetic chemistry bears an important role for breakthrough in future glycan imaging studies; the glyco-bioenvironment in vivo could be efficiently constructed in a combinatorial fashion, by integrating the synthetic chemistry and the glycobiology.
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